Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Rui M. Bernardino, Leyi B. Yin, Katherine Lajkosz, Eric Winqust, Jessica G. Cockburn, Pocharapong Jenjitranant, Rosette Veloso, Clare O’Connell, Aurora Mejia Benitez, Rune Matthiesen, Anthony M Joshua, Theodorus van der Kwast, Neil E. Fleshner
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Intraductal carcinoma predicts poor response to neoadjuvant therapy in high-risk prostate cancer: a retrospective analysis of a prospective trial
10.1016/j.euros.2025.09.015 · 2025
Guidelines for reporting of statistics for clinical research in urology
10.1016/j.eururo.2018.12.014 · 2019
Relaxing the rule of ten events per variable in logistic and cox regression
10.1093/aje/kwk052 · 2007
Grading of prostate cancer: a work in progress
10.1111/his.13767 · 2019
ISUP consensus definition of cribriform pattern prostate cancer
10.1097/pas.0000000000001728 · 2021
Analysis of separate training and validation radical prostatectomy cohorts identifies 25 mm diameter as an optimal definition for “large” cribriform prostatic adenocarcinoma
10.1038/s41379-022-01009-7 · 2022
Distinct adverse clinical outcomes of small and large cribriform patterns on Gleason 7 prostate cancer: a preliminary study
10.5152/tud.2023.23076 · 2023
Intraductal carcinoma and cribriform pattern in prostate cancer: challenges and emerging perspectives
10.1016/j.eururo.2025.01.013 · 2025
Undetected cribriform and intraductal prostate cancer at biopsy is associated with adverse outcomes
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1038/s41391-024-00910-3 · 2024
Limitations of prostate biopsy in detection of cribriform and intraductal prostate cancer
10.1016/j.euf.2023.08.010 · 2023
Intraductal prostate cancer affinity for lymphatic-predominant metastases through 18F-DCFPyL‒prostate-specific membrane antigen‒positron emission tomography/CT scans in pretreatment prostate cancer patients
10.1097/ju.0000000000003850 · 2024
Lymphotropic pattern of prostate-specific membrane antigen–detected metastases among biochemically recurrent radical prostatectomy patients with cribriform disease
10.1016/j.euf.2023.05.005 · 2023
Genomic alterations in intraductal prostate cancer: insights from the Genomic Umbrella neoadjuvant study (GUNS) in high-risk localized disease
10.1200/jco.2025.43.5_suppl.417 · 2025
No additional external references are available.